Landos Biopharma and Johns Hopkins School of Medicine Partner to Advance Oral Therapy

Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses Landos Biopharma and Johns Hopkins School of Medicine partnering to advance a potential Multiple Sclerosos (MS) oral therapy & reads the column by Jennifer Powell, Silver Linings, “Are You Prepared for a Fall?”===================================Treatment for Relapsing MS Progression | MAYZENT® (siponimod)Read about MAYZENT, a once daily pill that can significantly slow down disability progression in people with relapsing MS. See full prescribing & safety info.http://ChangesInRMS.com===================================== Are you interested in learning more about multiple sclerosis? If so, please visit:https://multiplesclerosisnewstoday.com/=====================================To join in on conversations regarding multiple sclerosis, please visit:https://multiplesclerosisnewstoday.com/forums/